J Menopausal Med.  2016 Dec;22(3):167-173. 10.6118/jmm.2016.22.3.167.

Decreased Renal Function Is a Risk Factor for Subclinical Coronary Atherosclerosis in Korean Postmenopausal Women

• Yun BH
• Chon SJ
• Cho SH
• Choi YS
• Lee BS
• Seo SK

• KMID: 2378237
• DOI: http://doi.org/10.6118/jmm.2016.22.3.167

Abstract

OBJECTIVES
Decreased renal function is associated with increased cardiovascular risk. Our study was planned to verify the association of decreased renal function and subclinical coronary atherosclerosis in postmenopausal women.
METHODS
We performed a retrospective review of 251 Korean postmenopausal women who visited the health promotion center for a routine health checkup. Estimated glomerular filtration rate (eGFR) was used to show renal function, which was estimated by calculated using the Cockcroft-Gault (CG) and the modification of diet in renal disease (MDRD) formulas. Coronary atherosclerosis was assessed by 64-row multidetector computed tomography.
RESULTS
Women with reduced eGFR (< 60 mL/minute/1.73 m²) had significantly higher brachial-ankle pulse wave velocity (baPWV) than women with normal eGFR (≥ 60 mL/minute/1.73 m²). The eGFR was negatively correlated with baPWV (r = -0.352, P < 0.001), significantly. The eGFR was lower in women with coronary atherosclerosis than in normal control women, markedly. Reduced eGFR was significantly associated with the presence of coronary atherosclerosis (odds ratio [OR] = 7.528, 95% confidence interval [CI] = 2.728-20.772, P < 0.001).
CONCLUSIONS
Decreased eGFR was closely associated with increased arterial stiffness and coronary atherosclerosis in postmenopausal women. Evaluating subclinical atherosclerosis by screening the renal function in postmenopausal women may be helpful screening high risk group and considering starting menopausal hormone therapy before atherosclerosis development.

Keyword

Coronary artery disease; Kidney function tests; Postmenopause; Vascular stiffness

MeSH Terms

Atherosclerosis
Coronary Artery Disease*
Diet
Female
Glomerular Filtration Rate
Health Promotion
Humans
Kidney Function Tests
Mass Screening
Multidetector Computed Tomography
Postmenopause
Pulse Wave Analysis
Retrospective Studies
Risk Factors*
Vascular Stiffness

Figure

• 

  Fig. 1 Simple correlation between brachial-ankle pulse wave velocity and estimated glomerular filtration rate (eGFR) according to eGFR values.

Reference

1. von der Recke P, Hansen MA, Hassager C. The association between low bone mass at the menopause and cardiovascular mortality. Am J Med. 1999; 106:273–278.

2. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004; 291:1701–1712.

3. Clarke SC, Kelleher J, Lloyd-Jones H, Slack M, Schofiel PM. A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT atherosclerosis study. BJOG. 2002; 109:1056–1062.

4. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998; 280:605–613.

5. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288:321–333.

6. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007; 297:1465–1477.

7. Mendelsohn ME, Karas RH. Molecular and cellular basis of cardiovascular gender differences. Science. 2005; 308:1583–1587.

8. Kurth T, de Jong PE, Cook NR, Buring JE, Ridker PM. Kidney function and risk of cardiovascular disease and mortality in women: a prospective cohort study. BMJ. 2009; 338:b2392.

9. Jung YS, Hwang HJ, Yun BH, Chon SJ, Cho S, Choi YS, et al. Renal function is associated with bone mineral density and arterial stiffness in healthy postmenopausal women. Gynecol Obstet Invest. 2014; 78:124–129.

10. Seo SK, Cho S, Kim HY, Choi YS, Park KH, Cho DJ, et al. Bone mineral density, arterial stiffness, and coronary atherosclerosis in healthy postmenopausal women. Menopause. 2009; 16:937–943.

11. Yun BH, Chon SJ, Lee YJ, Han EJ, Cho S, Choi YS, et al. Association of metabolic syndrome with coronary atherosclerosis in non-diabetic postmenopausal women. Climacteric. 2015; 18:284–289.

12. Achenbach S, Moselewski F, Ropers D, Ferencik M, Hoffmann U, MacNeill B, et al. Detection of calcified and noncalcified coronary atherosclerotic plaque by contrast-enhanced, submillimeter multidetector spiral computed tomography: a segment-based comparison with intravascular ultrasound. Circulation. 2004; 109:14–17.

13. Yi SS, Hwang E, Baek HK, Kim TH, Lee HH, Jun HS, et al. Application of bioactive natural materials-based products on five women's diseases. J Menopausal Med. 2015; 21:121–125.

14. Ahmed K, Jahan P, Nadia I, Ahmed F, Abdullah Al E. Assessment of menopausal symptoms among early and late menopausal midlife Bangladeshi women and their impact on the quality of life. J Menopausal Med. 2016; 22:39–46.

15. Jeon GH, Kim SH, Kim SR, Chae HD, Kim CH, Kang BM. The association between serum estradiol level and coronary artery calcification in postmenopausal women: a preliminary report. J Korean Soc Menopause. 2010; 16:16–22.

16. Viazzi F, Cappadona F, Pontremoli R. Microalbuminuria in primary hypertension: a guide to optimal patient management? J Nephrol. 2016; 29:747–753.

17. Pedrinelli R, Dell'Omo G, Di Bello V, Pontremoli R, Mariani M. Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension. J Hum Hypertens. 2002; 16:79–89.

18. Leoncini G, Viazzi F, Parodi D, Ratto E, Vettoretti S, Vaccaro V, et al. Mild renal dysfunction and cardiovascular risk in hypertensive patients. J Am Soc Nephrol. 2004; 15:Suppl 1. S88–S90.

19. Choi SW, Kim HY, Lee YH, Ryu SY, Kweon SS, Rhee JA, et al. eGFR is associated with subclinical atherosclerosis independent of albuminuria: the Dong-gu Study. Atherosclerosis. 2010; 212:661–667.

20. Astor BC, Arnett DK, Brown A, Coresh J. Association of kidney function and hemoglobin with left ventricular morphology among African Americans: the Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis. 2004; 43:836–845.

21. Miyatake N, Shikata K, Makino H, Numata T. Relation between the estimated glomerular filtration rate and pulse wave velocity in Japanese. Intern Med. 2010; 49:1315–1320.